Authors:
Newkirk, KA
Cullen, KJ
Harter, KW
Picken, CA
Sessions, RB
Davidson, BJ
Citation: Ka. Newkirk et al., Planned neck dissection for advanced primary head and neck malignancy treated with organ preservation therapy: Disease control and survival outcomes, HEAD NECK, 23(2), 2001, pp. 73-79
Authors:
Shiga, H
Rasmussen, AA
Johnston, PG
Langmacher, M
Baylor, A
Lee, M
Cullen, KJ
Citation: H. Shiga et al., Prognostic value of c-erbB2 and other markers in patients treated with chemotherapy for recurrent head and neck cancer, HEAD NECK, 22(6), 2000, pp. 599-608
Citation: An. Salesiotis et Kj. Cullen, Molecular markers predictive of response and prognosis in the patient withadvanced squamous cell carcinoma of the head and neck: evolution of a model beyond TNM staging, CURR OPIN O, 12(3), 2000, pp. 229-239
Authors:
Agurs-Collins, T
Adams-Campbell, LL
Kim, KS
Cullen, KJ
Citation: T. Agurs-collins et al., Insulin-like growth factor-1 and breast cancer risk in postmenopausal African-American women, CANCER DET, 24(3), 2000, pp. 199-206
Authors:
Yang, ZJ
Faustino, PJ
Andrews, PA
Monastra, R
Rasmussen, AA
Ellison, CD
Cullen, KJ
Citation: Zj. Yang et al., Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines, CANC CHEMOT, 46(4), 2000, pp. 255-262
Authors:
Shiga, H
Heath, EI
Rasmussen, AA
Trock, B
Johnston, PG
Forastiere, AA
Langmacher, M
Baylor, A
Lee, M
Cullen, KJ
Citation: H. Shiga et al., Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer, CLIN CANC R, 5(12), 1999, pp. 4097-4104
Citation: Kj. Cullen et al., Interactions between stroma and epithelium in breast cancer - Implicationsfor tumor genesis, growth, and progression, CONT ENDOC, 11, 1999, pp. 155-168